USPTO 2015–2025 USPTO PatentsView US Corporation

Relamp

USPTO PatentsView assignee record - 13 granted patents across 0 technology areas, recorded in grant years 2019–2019. Grant-trend analysis is cross-referenced to USPTO Patent Public Search; it does not measure application filings, current R&D, or legal strength.

The verdict

According to USPTO PatentsView, Relamp ranks #21,680 of 50,000 tracked US assignees by granted-patent volume, with 13 patents across 0 technology areas.

#21,680
of 50,000 US assignees by volume
Top 99%
by Innovation Score (9.7/100)
1.0
avg claims per patent
-100%
grant velocity, last 5 yrs

USPTO PatentsView assignee plate

Corpus R21680 · US Corporation #21,680 · 13 grants

GRANTS-MICRO · MID-PACK · PHOTO-FINISH · CPC-UNK · INNOV-LOW · CLAIMS-SPARSE · TYPE-USCORP · VEL-DROP · BOOK-RICH

  • GRANTS-MICRO 13 grants
  • MID-PACK #21,680/50,000
  • PHOTO-FINISH RedShift BioAnalytics
  • CPC-UNK CPC blank
  • INNOV-LOW 9.7/100
  • CLAIMS-SPARSE 1.0 claims/avg
  • TYPE-USCORP US Corporation
  • VEL-DROP -100% vel
  • BOOK-RICH 9/10 fields

Nearest grant-volume peer: Redshift Bioanalytics Inc. (±0 grants)

Instrument codes from this assignee’s USPTO PatentsView grant sheet: volume band, corpus rank, photo-finish peer, lead CPC, Innovation Score, claim depth, assignee type, velocity, and book completeness. Not a USPTO rating of patent strength.

Innovation-score neighbourhood around Relamp

Lowest and highest poles plus nearest Innovation Score peers, not a full corpus board reprint.

score

What this shows Relamp's Innovation Score is 9.7/100 (top 99% of the PatentsView-derived corpus). The chart places that score against the nearest Innovation Score peers plus corpus poles, not a reprint of the volume ranking.

Source USPTO PatentsView, PlainPatent Innovation Score As of 2015–2025

Where Relamp's grants concentrate

Relamp is a focused PatentsView assignee: 0 CPC subclasses . By volume, Relamp sits between Redshift Bioanalytics Inc. and Respiratory Motion, Inc..

Who files at Relamp's volume?

Granted US patents 2015–2025 versus its nearest-ranked assignees by volume, this company marked ◀

patents

What this shows Relamp holds 13 patents at rank #21,693, shown against the 8 assignees closest to it in grant volume rather than the industry's largest filers.

Source USPTO PatentsView, granted utility patents As of 2015–2025

Companies ranked near Relamp

By rank, the assignees closest to #21,693 in granted patent volume.

Relamp's Innovation Score vs. every tracked assignee

Composite of portfolio volume, grant velocity, technology breadth, and claim depth (0–100)

10 Top 99% higher than 1% of 50,000 US assignees

0–10: 687 US assignees (1%). Below this entry. 10–20: 2,527 US assignees (5%). This entry sits in this band. 20–30: 13,162 US assignees (26%). Above this entry. 30–40: 15,294 US assignees (31%). Above this entry. 40–50: 11,491 US assignees (23%). Above this entry. 50–60: 5,058 US assignees (10%). Above this entry. 60–70: 1,537 US assignees (3%). Above this entry. 70–80: 234 US assignees (0%). Above this entry. 80–90: 10 US assignees (0%). Above this entry. 90–100: 0 US assignees (0%). Above this entry. This assignee 0 100 every tracked assignee, bucketed by value

Each bar is a band; taller bars hold more US assignees. The dashed line + filled bar mark this entry. Hover or tap any bar for its full count, share, and where it sits relative to this entry.

Source USPTO PatentsView, PlainPatent Innovation Score · 2015–2025

Grants by year

Teal-shaded recent years (2020–present) versus the 2019–2019 baseline. Full figures in the table below.

View data table
Relamp patent grants by year, 2015–2025
Year Patents Granted Share of Period
2019 13 100.0%

Where it ranks

Overall rank by patents

#21,680

of 50,000 tracked assignees

Innovation Score

9.7 out of 100

View all rankings →

Data Source

USPTO PatentsView, US granted patents 2015–2025

How is Innovation Score calculated?

Every figure on PlainPatent is rendered directly from USPTO source data, no number is typed in by an editor. This page draws directly on USPTO source data, no figure is typed in by an editor. See our editorial standards & corrections policy, the methodology behind these numbers, or report a data error. Data current as of May 2026.